Volume 24, Number 1—January 2018
Research Letter
Dengue Fever in Burkina Faso, 2016
Table
Characteristics and rRT-PCR results of patients with dengue fever, Burkina Faso, 2016*
20–29 | 8/35 (22.85) | NA |
---|---|---|
30–39 | 9/35 (25.71) | NA |
40–49 | 9/35 (25.71) | NA |
≥50 | 2/35 (5.71) | NA |
Unknown | 2/35 (5.71) | NA |
Sex | ||
M | 24/35 (68.57) | NA |
F | 8/35 (22.85) | NA |
Unknown |
3/35 (8.57) |
NA |
Molecular diagnostic | ||
rRT-PCR trioplex | 19/35 (54.3) | 34.78–70.78 |
rRT-PCR DENV-1–4 | 17/19 (89.4) | 75.68–103.26 |
DENV-1 | 0 (0) | NA |
DENV-2 | 11/19 (57.8) | 35.69–80.09 |
DENV-3 | 6/19 (31.5) | 11.57–51.57 |
DENV-4 | 0 (0) | NA |
DENV-2 + DENV-3 | 1/19 (5.26) | 4.74–15.26 |
Unknown serotype | 2/19 (10.5) | 7.2–23.52 |
*Of the 35 patient samples used, 31 were positive and 4 were negative by SD BIOLINE Dengue Duo (Standard Diagnostics, Seoul, South Korea). DENV, dengue virus; NA, not applicable; rRT-PCR, real-time reverse transcription PCR.
Page created: December 19, 2017
Page updated: December 19, 2017
Page reviewed: December 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.